Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1014 results for "novartis"

Novartis India Q1 net up 3 per cent at Rs. 14.31 crore
MSN India

NOVARTIS INDIA : NET RISES 3% AT Rs14.31 CRORE

Novartis India has registered a growth of 3.17 percent in standalone net profit at Rs14.31 crore in Apr- Jun 2014 from Rs13.87 crore in Apr- Jun 2013 . The net sales fell to Rs202.06 crore from Rs219.03 4 Traders, 28 minutes ago
[x]  

1,386 images for novartis

Orlando Sentinel, 21 hours ago
Yahoo! News, 21 hours ago
Reuters, 20 hours ago
MSN India, 3 days ago
BioSpace, 3 days ago
Sify, 1 week ago
Deutsche Welle, 4 days ago
FiercePharma, 15 hours ago
TopNews United States, 1 week ago
Bidness Etc, 1 week ago

EU approves Alcon's Simbrinza eye drops to treat patients with glaucoma

Alcon, the global leader in eye care and a division of Novartis, announced that Simbrinza eye drops suspension (brinzolamide 10mg/mL and brimonidine tartrate 2mg/mL) has been approved by the European Commission to decrease elevated intraocular ...
 PharmaBiz30 minutes ago Novartis Says Alcon's Simbrinza Gets EU Approval To Treat Glaucoma  RTTNews.com1 day ago Novartis vaccine Bexsero┬« sees high uptake in first large-scale public vaccination program to help protect against devastating meningitis B  SPi World News1 hour ago Alcon's Simbrinza approved for glaucoma in the EU  Pharma Letter19 hours ago
[x]  

Novartis Division Gets European Approval for Simbrinza

Novartis ( NVS ) ophthalmology division, Alcon, received encouraging news when Simbrinza was approved by the European Commission. Simbrinza has been approved in Europe to decrease elevated intraocular pressure (:IOP) in adult patients with ...
 Yahoo! Finance9 hours ago Novartis' glaucoma therapy Simbrinza approved in Europe  FirstWord Pharma19 hours ago
FOXNews.com

New glaucoma treatment approved

Swiss pharmaceutical group Novartis said the European Commission has approved its eyecare unit Alcon's Simbrinza treatment for glaucoma, a chronic, sight-threatening eye disease. Alcon said in a statement on Monday the Simbrinza eye drops ...
 FOXNews.com17 hours ago Novartis says Alcon glaucoma treatment approved in EU  Reuters1 day ago Novartis glaucoma treatment approved in Europe  MedCity News17 hours ago
[x]  

Novartis AG (NVS) Trading Near $89.02 Resistance Level

%ccnetdebit% net debit. This trade has an assigned return of 2.15% but the downside protection increases to 3.11%. Standard & PooraEUR(TM)s has a 4 STARS (out of 5) buy ranking and a 12-month target price of $99.00 on Novartis AG. Over the last 52 ...
 Individual.com12 hours ago

Omalizumab Effective for Chronic Hives up to 24 Weeks

Omalizumab ( Xolair , Genentech Inc and Novartis Pharmaceuticals Corporation) is effective at controlling chronic hives for up to 24 weeks, according to results of a clinical trial by Sarbjit S. Saini, MD, from the Johns Hopkins Asthma and Allergy ...
 American Journal of Public Health16 hours ago

Novartis Earnings Review: 11 Days after Announcement Shares Down 0.1% (NVS)

A week ago on July 17th, 2014 Novartis (NYSE:NVS) reported earnings and analysts, on average, expected earnings of $1.36 on sales of $14.8 billion. Novartis actually reported a break-even quarter on sales of $13.4 billion, missing EPS estimates by ...
 Individual.com18 hours ago

Novartis Biotechnology Leadership Camp selects three women

They will represent India at International BioCamp in Basle, Switzerland Three women, Satarupa Barma and Aditi Ramnath from the Indian School of Business (ISB), Hyderabad and Nidhi Hans pursuing a PhD at the International Centre for Genetic ...
 Express Pharma3 days ago Women students take top slots at Novartis BioCamp  Hindu Business Line3 days ago

Novartis India Q1 profit rises to Rs 14.3 cr

The company's net sales were down at Rs 202 crore versus Rs 219 crore, Y-o-Y.
 Money Control3 days ago Novartis India Q1 PAT at Rs 14.3 cr  Money Control3 days ago

Novartis India: Outcome of AGM

Novartis India has informed that the Annual General Meeting (AGM) of the Company was held on July 25, 2014.
 Money Control3 days ago Novartis India's AGM on July 25, 2014  Money Control3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less